메뉴 건너뛰기




Volumn 171, Issue 19, 2011, Pages 1718-1720

Cardiovascular risk stratification, hemoglobin A 1c, and the tempo of translation

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 80054915791     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.352     Document Type: Note
Times cited : (2)

References (15)
  • 1
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
    • (2001) JAMA , vol.285 , Issue.19 , pp. 2486-2497
  • 2
    • 70349976327 scopus 로고    scopus 로고
    • Using nontraditional risk factors in coronary heart disease risk assessment: US Preventive Services Task Force recommendation statement
    • US Preventive Services Task Force
    • US Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(7):474-482.
    • (2009) Ann Intern Med , vol.151 , Issue.7 , pp. 474-482
  • 4
    • 70349742564 scopus 로고    scopus 로고
    • C-reactive protein as a risk factor for coronary heart disease: A systematic review and metaanalyses for the US Preventive Services Task Force
    • Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and metaanalyses for the US Preventive Services Task Force. Ann Intern Med. 2009;151(7):483-495.
    • (2009) Ann Intern Med. , vol.151 , Issue.7 , pp. 483-495
    • Buckley, D.I.1    Fu, R.2    Freeman, M.3    Rogers, K.4    Helfand, M.5
  • 5
    • 33846996345 scopus 로고    scopus 로고
    • Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score
    • Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297(6):611-619.
    • (2007) JAMA , vol.297 , Issue.6 , pp. 611-619
    • Ridker, P.M.1    Buring, J.E.2    Rifai, N.3    Cook, N.R.4
  • 6
    • 38849091997 scopus 로고    scopus 로고
    • Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
    • Pencina MJ, D'Agostino RBS Sr, D'Agostino RBJ Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172, 207-212.
    • (2008) Stat Med. , vol.27 , Issue.2
    • Pencina, M.J.1    D'Agostino Sr., R.B.S.2    D'Agostino Jr., R.B.J.3    Vasan, R.S.4
  • 7
    • 56749154191 scopus 로고    scopus 로고
    • Assessing new biomarkers and predictive models for use in clinical practice: A clinician's guide
    • McGeechan K, Macaskill P, Irwig L, Liew G, Wong TY. Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch Intern Med. 2008;168(21):2304-2310.
    • (2008) Arch Intern Med , vol.168 , Issue.21 , pp. 2304-2310
    • McGeechan, K.1    Macaskill, P.2    Irwig, L.3    Liew, G.4    Wong, T.Y.5
  • 10
    • 79953035510 scopus 로고    scopus 로고
    • Evaluating the clinical utility of a biomarker: A review of methods for estimating health impact
    • Pletcher MJ, Pignone M. Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact. Circulation. 2011;123(10):1116-1124.
    • (2011) Circulation. , vol.123 , Issue.10 , pp. 1116-1124
    • Pletcher, M.J.1    Pignone, M.2
  • 11
    • 33644868473 scopus 로고    scopus 로고
    • Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age
    • Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113(6):791-798.
    • (2006) Circulation. , vol.113 , Issue.6 , pp. 791-798
    • Lloyd-Jones, D.M.1    Leip, E.P.2    Larson, M.G.3
  • 12
    • 77955500531 scopus 로고    scopus 로고
    • Nonoptimal lipids commonly present in young adults and coronary calcium later in life: The CARDIA (Coronary Artery Risk Development in Young Adults) study
    • Pletcher MJ, Bibbins-Domingo K, Liu K, et al. Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Ann Intern Med. 2010;153(3):137-146.
    • (2010) Ann Intern Med. , vol.153 , Issue.3 , pp. 137-146
    • Pletcher, M.J.1    Bibbins-Domingo, K.2    Liu, K.3
  • 13
    • 77955697561 scopus 로고    scopus 로고
    • Earlier intervention in the management of hypercholesterolemia: What are we waiting for?
    • Steinberg D. Earlier intervention in the management of hypercholesterolemia: what are we waiting for? J Am Coll Cardiol. 2010;56(8):627-629.
    • (2010) J Am Coll Cardiol. , vol.56 , Issue.8 , pp. 627-629
    • Steinberg, D.1
  • 14
    • 33646368931 scopus 로고    scopus 로고
    • Diabetes and coronary risk equivalency: What does it mean?
    • Grundy SM. Diabetes and coronary risk equivalency: what does it mean? Diabetes Care. 2006;29(2):457-460. (Pubitemid 44106538)
    • (2006) Diabetes Care , vol.29 , Issue.2 , pp. 457-460
    • Grundy, S.M.1
  • 15
    • 79955569726 scopus 로고    scopus 로고
    • What next for QALYs?
    • Neumann PJ. What next for QALYs? JAMA. 2011;305(17):1806-1807.
    • (2011) JAMA. , vol.305 , Issue.17 , pp. 1806-1807
    • Neumann, P.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.